HealthyDirect · Growth
Kotak Healthcare Fund
Kotak Mahindra Mutual FundEquity Scheme - Sectoral/ Thematic2.7 years
The scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.
- NAV
- 17.724
- 15 Sept 2026
- 1Y
- +26.5%
- Trailing CAGR
- AUM
- ₹767.7 Cr
- 31 Aug 2026
- Volatility
- Medium
- 14.4% annualized
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+26.5%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+23.0%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+41.0%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +23.0%
- Calendar-day CAGR
- Excess 1Y
- +20.5%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
Drawdown
Peak to trough from a running NAV high. Move across the path to read a date.
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 14 days
- 41 recovered episodes
- Longest recovery
- 427 days
- Trough to prior peak
- Current spell
- 5 days
- Days below latest peak
- Time below peak
- +83%
- NAV observations
2 Jan 2025 – 4 May 2026
Trough 3 Mar 2025 · recovered in 427 days
-18.0%
27 Sept 2024 – 2 Dec 2024
Trough 18 Nov 2024 · recovered in 14 days
-5.5%
23 Feb 2024 – 10 Jun 2024
Trough 4 Jun 2024 · recovered in 6 days
-5.2%
21 Jul 2026 – 29 Jul 2026
Trough 24 Jul 2026 · recovered in 5 days
-2.3%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
81
Vs category
100
Consistency
81
Risk-adjusted
84
Drawdown
55
Mean
80
Portfolio
31 Aug 2026 · 36 holdings · top 10 are 54.3%.
- Top 5
- 36.8%
- Top 10
- 54.3%
- Largest holding
- 14.0%
- Effective holdings
- 19.9
Sun Pharmaceutical Industries Ltd
Healthcare
14.0%
Divi's Laboratories Ltd
Healthcare
9.3%
Torrent Pharmaceuticals Ltd
Healthcare
4.8%
Molbio Diagnostics Ltd.
Healthcare
4.5%
Max Healthcare Institute Ltd
Healthcare
4.3%
Decision
Quantitative read of the live evidence. An explanation can only restate what is already here.
As of 15 Sept 2026
Healthy
Engine status
Healthy
Doing its job
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 81% of rolling 1-year windows.
- Risk-adjusted return sits above the documented risk-free proxy.
Worth investigating
Same-category peers with enough history to inspect beside this fund.
Kotak Business Cycle Fund
Kotak Mahindra Mutual Fund
- 1Y
- +2.5%
- 3Y
- +14.5%
- Vol
- 12.6%
- Max DD
- -18.4%
- Sharpe
- 0.82
- 3Y win
- +97%
- Lower volatility
- Higher win rate vs category
- Lower TER
Caveat: Deeper drawdown · Lower trailing returns
Motilal Oswal Active Momentum Fund
Motilal Oswal Mutual Fund
- 1Y
- +25.5%
- 3Y
- n/a
- Vol
- 17.1%
- Max DD
- -16.6%
- Sharpe
- 1.25
- 3Y win
- n/a
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher volatility · Higher TER · Lower trailing returns
Nippon India Innovation Fund
Nippon India Mutual Fund
- 1Y
- +0.2%
- 3Y
- +13.9%
- Vol
- 14.1%
- Max DD
- -21.5%
- Sharpe
- 0.68
- 3Y win
- +100%
- Lower volatility
- Higher win rate vs category
Caveat: Deeper drawdown · Lower trailing returns
Aditya Birla Sun Life Business Cycle Fund
Aditya Birla Sun Life Mutual Fund
- 1Y
- +5.9%
- 3Y
- +11.6%
- Vol
- 13.8%
- Max DD
- -17.8%
- Sharpe
- 0.48
- 3Y win
- +7%
- Lower volatility
- Shallower drawdown
Caveat: Higher TER · Lower trailing returns
Baroda BNP Paribas Energy Opportunities Fund
Baroda BNP Paribas Mutual Fund
- 1Y
- +0.7%
- 3Y
- n/a
- Vol
- 13.8%
- Max DD
- -9.7%
- Sharpe
- 0.33
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
Caveat: Higher TER · Lower trailing returns